Unknown

Dataset Information

Regulatory delays in a multinational clinical stroke trial.


ABSTRACT:

Introduction

The initiation and conduct of randomised clinical trials are complicated by multiple barriers, including delays in obtaining regulatory approvals. Quantitative data on the extent of the delays due to national or local review in randomised clinical trials is scarce.

Materials and methods

We assessed the times needed to obtain regulatory approval and to initiate a trial site for an academic, EU-funded, phase III, randomised clinical trial of pharmacological prevention of complications in patients with acute stroke in over 80 sites in nine European countries. The primary outcome was the time from the first submission to a regulatory authority to initiation of a trial site. Secondary outcomes included time needed to complete each individual preparatory requirement a

SUBMITTER: de Jonge JC 

PROVIDER: S-EPMC8370076 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature